|
|
Volumn 43, Issue 2, 2008, Pages 144-153
|
|
Modification of perioperative drug therapy in cardiovascular, pulmonary or metabolic disease;Perioperative modifikation der dauermedikation bei kardiovaskulären, pulmonalen und metabolischen erkrankungen
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE;
AMLODIPINE BESYLATE;
ATORVASTATIN;
BISOPROLOL;
BISOPROLOL FUMARATE;
BUDESONIDE;
CANDESARTAN;
CANDESARTAN HEXETIL;
CAPTOPRIL;
CARVEDILOL;
CICLESONIDE;
CLONIDINE;
CLOPIDOGREL;
DIGITOXIN;
DIGOXIN;
ENALAPRIL;
ENALAPRIL MALEATE;
FENOTEROL;
FLUINDOSTATIN;
FLUTICASONE PROPIONATE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FORMOTEROL;
FUROSEMIDE;
GLIBENCLAMIDE;
GLIMEPIRIDE;
HYDROCHLOROTHIAZIDE;
IPRATROPIUM BROMIDE;
IRBESARTAN;
ISOSORBIDE DINITRATE;
LISINOPRIL;
LOSARTAN;
LOSARTAN POTASSIUM;
METFORMIN;
MEVINOLIN;
MOLSIDOMINE;
MOXONIDINE;
NATEGLINIDE;
NEBIVOLOL;
NIFEDIPINE;
NITRENDIPINE;
PIOGLITAZONE;
PRAVASTATIN;
RAMIPRIL;
REPAGLINIDE;
ROSIGLITAZONE;
SALBULAIR;
SALMETEROL XINAFOATE;
SIMVASTATIN;
SPIRONOLACTONE;
TICLOPIDINE;
TIOTROPIUM BROMIDE;
TORASEMIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALSARTAN;
ANESTHESIA;
ARTICLE;
ASTHMA;
CARDIOVASCULAR DISEASE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DIABETES MELLITUS;
HEART EJECTION FRACTION;
HEART MUSCLE ISCHEMIA;
HEART SURGERY;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
HYPERCHOLESTEROLEMIA;
INCIDENCE;
INTRAOPERATIVE PERIOD;
LUNG DISEASE;
METABOLIC DISORDER;
MUSCLE HYPERTONIA;
PERIOPERATIVE PERIOD;
PHYSICAL CHEMISTRY;
POSTOPERATIVE PERIOD;
RISK BENEFIT ANALYSIS;
TREATMENT DURATION;
ANESTHESIA;
CARDIOVASCULAR DISEASES;
GERMANY;
HUMANS;
LUNG DISEASES;
METABOLIC DISEASES;
PERIOPERATIVE CARE;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
PREMEDICATION;
QUALITY ASSURANCE, HEALTH CARE;
|
|
EID: 39849092618
PISSN: 09392661
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2008-1060548 Document Type: Article |
|
Times cited : (6)
|
|
References (17)
|
